208 related articles for article (PubMed ID: 29862285)
1. Fertility Drugs Associated with Thyroid Cancer Risk: A Systematic Review and Meta-Analysis.
Yu Q; Lv X; Liu K; Ma D; Wu Y; Dai W; Jiang H
Biomed Res Int; 2018; 2018():7191704. PubMed ID: 29862285
[TBL] [Abstract][Full Text] [Related]
2. Thyroid cancer risk in women with infertility and association with fertility medications in Taiwan.
Ding DC; Chen W; Wang JH; Lin SZ; Sung FC
Cancer; 2019 May; 125(10):1701-1708. PubMed ID: 30645760
[TBL] [Abstract][Full Text] [Related]
3. Fertility drugs and incidence of thyroid cancer in a Danish nationwide cohort of 146 024 infertile women.
Lindquist S; Kjær SK; Albieri V; Frederiksen K; Hansen T; Nøhr B; Jensen A
Hum Reprod; 2022 Apr; 37(4):838-847. PubMed ID: 35020884
[TBL] [Abstract][Full Text] [Related]
4. Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility.
Skalkidou A; Sergentanis TN; Gialamas SP; Georgakis MK; Psaltopoulou T; Trivella M; Siristatidis CS; Evangelou E; Petridou E
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010931. PubMed ID: 28349511
[TBL] [Abstract][Full Text] [Related]
5. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs.
Althuis MD; Scoccia B; Lamb EJ; Moghissi KS; Westhoff CL; Mabie JE; Brinton LA
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):668-74. PubMed ID: 16150258
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy registry: three-year follow-up of children conceived from letrozole, clomiphene, or gonadotropins.
Legro RS; Diamond MP; Coutifaris C; Schlaff WD; Alvero R; Casson P; Christman GM; Rosen RM; Cedars MI; Hansen KR; Robinson R; Baker V; Usadi R; Dodson WC; Estes SJ; Kunselman A; Stetter C; Barnhart KT; Coward RM; Trussell JC; Krawetz SA; Santoro N; Huang H; Zhang H; Eisenberg E;
Fertil Steril; 2020 May; 113(5):1005-1013. PubMed ID: 32386612
[TBL] [Abstract][Full Text] [Related]
7. Ovarian cancer risk after the use of ovulation-stimulating drugs.
Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
[TBL] [Abstract][Full Text] [Related]
8. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study.
Hannibal CG; Jensen A; Sharif H; Kjaer SK
Hum Reprod; 2008 Feb; 23(2):451-6. PubMed ID: 18065402
[TBL] [Abstract][Full Text] [Related]
9. Progesterone luteal support after ovulation induction and intrauterine insemination: an updated systematic review and meta-analysis.
Green KA; Zolton JR; Schermerhorn SM; Lewis TD; Healy MW; Terry N; DeCherney AH; Hill MJ
Fertil Steril; 2017 Apr; 107(4):924-933.e5. PubMed ID: 28238492
[TBL] [Abstract][Full Text] [Related]
10. Use of Fertility Drugs and Risk of Malignant Melanoma: Results from a Large Danish Population-Based Cohort Study.
Freund L; Kjær SK; Guleria S; Albieri V; Nybo Andersen AM; Frederiksen K; Jensen A
J Invest Dermatol; 2021 Sep; 141(9):2189-2196.e1. PubMed ID: 33741390
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk after exposure to fertility drugs.
Lo Russo G; Spinelli GP; Tomao S; Rossi B; Frati L; Panici PB; Vici P; Codacci Pisanelli G; Tomao F
Expert Rev Anticancer Ther; 2013 Feb; 13(2):149-57. PubMed ID: 23406556
[TBL] [Abstract][Full Text] [Related]
12. Risk of colorectal cancer after use of fertility drugs-results from a large Danish population-based cohort of women with infertility.
Møller M; Kjær SK; Lindquist S; Brown Frandsen CL; Albieri V; Viuff JH; Nøhr B; Olsen A; Jensen A
Fertil Steril; 2022 Oct; 118(4):738-747. PubMed ID: 36041966
[TBL] [Abstract][Full Text] [Related]
13. A study of infertility treatment and melanoma.
Young P; Purdie D; Jackman L; Molloy D; Green A
Melanoma Res; 2001 Oct; 11(5):535-41. PubMed ID: 11595893
[TBL] [Abstract][Full Text] [Related]
14. Drugs in infertility.
Br Med J; 1972 Oct; 4(5833):167-70. PubMed ID: 5078452
[No Abstract] [Full Text] [Related]
15. Effects of fertility drugs on cancers other than breast and gynecologic malignancies.
Brinton LA; Moghissi KS; Scoccia B; Lamb EJ; Trabert B; Niwa S; Ruggieri D; Westhoff CL
Fertil Steril; 2015 Oct; 104(4):980-988. PubMed ID: 26232746
[TBL] [Abstract][Full Text] [Related]
16. Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study.
Jensen A; Sharif H; Kjaer SK
Am J Epidemiol; 2009 Dec; 170(11):1408-14. PubMed ID: 19884127
[TBL] [Abstract][Full Text] [Related]
17. Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis.
Beebeejaun Y; Athithan A; Copeland TP; Kamath MS; Sarris I; Sunkara SK
Fertil Steril; 2021 Jul; 116(1):198-207. PubMed ID: 34148584
[TBL] [Abstract][Full Text] [Related]
18. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer risk associated with ovulation-stimulating drugs.
Brinton LA; Scoccia B; Moghissi KS; Westhoff CL; Althuis MD; Mabie JE; Lamb EJ
Hum Reprod; 2004 Sep; 19(9):2005-13. PubMed ID: 15217997
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study.
Orgéas CC; Sanner K; Hall P; Conner P; Holte J; Nilsson SJ; Sundfeldt K; Persson I; Chia KS; Wedren S; Dickman PW; Czene K
Am J Obstet Gynecol; 2009 Jan; 200(1):72.e1-7. PubMed ID: 19121659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
